These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2889827)

  • 1. Differential serotonin2 receptor recovery in mature and senescent rat brain after irreversible receptor modification: effect of chronic reserpine treatment.
    Battaglia G; Norman AB; Creese I
    J Pharmacol Exp Ther; 1987 Oct; 243(1):69-75. PubMed ID: 2889827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential recovery rates of rat D2 dopamine receptors as a function of aging and chronic reserpine treatment following irreversible modification: a key to receptor regulatory mechanisms.
    Norman AB; Battaglia G; Creese I
    J Neurosci; 1987 May; 7(5):1484-91. PubMed ID: 2952771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related differential recovery rates of rat striatal D-1 dopamine receptors following irreversible inactivation.
    Battaglia G; Norman AB; Creese I
    Eur J Pharmacol; 1988 Jan; 145(3):281-90. PubMed ID: 2895004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
    Lyon RA; Davis KH; Titeler M
    Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term treatment with desipramine increases the turnover of alpha 2-adrenoceptors in the rat brain.
    Barturen F; Garcia-Sevilla JA
    Mol Pharmacol; 1992 Nov; 42(5):846-55. PubMed ID: 1359398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between alpha 2-adrenergic receptor binding sites and the functional receptors inhibiting norepinephrine release in rat cerebral cortex.
    Nasseri A; Minneman KP
    Mol Pharmacol; 1987 Nov; 32(5):655-62. PubMed ID: 2891027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of serotonin2 (5-HT2) receptors labeled with [3H]spiroperidol by chronic treatment with the antidepressant amitriptyline.
    Peroutka SJ; Snyder SH
    J Pharmacol Exp Ther; 1980 Dec; 215(3):582-7. PubMed ID: 6255132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noradrenergic denervation alters serotonin2-mediated behavior but not serotonin2 receptor number in rats: modulatory role of beta adrenergic receptors.
    Eison AS; Yocca FD; Gianutsos G
    J Pharmacol Exp Ther; 1988 Aug; 246(2):571-7. PubMed ID: 2900327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor alterations associated with serotonergic agents: an autoradiographic analysis.
    Wamsley JK; Byerley WF; McCabe RT; McConnell EJ; Dawson TM; Grosser BI
    J Clin Psychiatry; 1987 Mar; 48 Suppl():19-25. PubMed ID: 3029045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced alpha2A-autoreceptor reserve for clonidine induced by reserpine and cholinomimetic agents in the rat vas deferens.
    Pineda J; Ugedo L; García-Sevilla JA
    Br J Pharmacol; 1997 Nov; 122(5):833-40. PubMed ID: 9384498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-H-ketanserin (serotonin type 2) binding in the rat frontal cortex: effect of immobilization stress.
    Torda T; Culman J; Cechová E; Murgas K
    Endocrinol Exp; 1988 Jun; 22(2):99-105. PubMed ID: 3261685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Turnover of beta 1- and beta 2-adrenergic receptors after down-regulation or irreversible blockade.
    Neve KA; Molinoff PB
    Mol Pharmacol; 1986 Aug; 30(2):104-11. PubMed ID: 3016496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential inactivation and G protein reconstitution of subtypes of [3H]5-hydroxytryptamine binding sites in brain.
    Stratford CA; Tan GL; Hamblin MW; Ciaranello RD
    Mol Pharmacol; 1988 Oct; 34(4):527-36. PubMed ID: 3139989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptation of brain 5HT2 receptors after mianserin treatment: receptor sensitivity, not receptor binding, more accurately correlates with behavior.
    Smith RL; Barrett RJ; Sanders-Bush E
    J Pharmacol Exp Ther; 1990 Aug; 254(2):484-8. PubMed ID: 2166792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) administration for studies of 5-HT1A receptor binding site inactivation and turnover.
    Keck BJ; Lakoski JM
    Brain Res Brain Res Protoc; 1997 Oct; 1(4):364-70. PubMed ID: 9384817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Species differences in the pharmacology of the 5-hydroxytryptamine2 receptor: structurally specific differentiation by ergolines and tryptamines.
    Nelson DL; Lucaites VL; Audia JE; Nissen JS; Wainscott DB
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1272-9. PubMed ID: 8510008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated peripheral administration of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin alters the binding activities of 5-HT1A and 5-HT2 receptors in rat brain.
    Muguruma K; Imamura K; Watanabe Y
    Biochem Biophys Res Commun; 1996 Oct; 227(3):794-9. PubMed ID: 8886012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo irreversible blockade of cortical S2 serotonin receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline: a technique for investigating S2 serotonin receptor recovery.
    Battaglia G; Norman AB; Newton PL; Creese I
    J Neurochem; 1986 Feb; 46(2):589-93. PubMed ID: 2934516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative recovery kinetics of 5-hydroxytryptamine 1A, 1B, and 2A receptor subtypes in rat cortex after receptor inactivation: evidence for differences in receptor production and degradation.
    Pinto W; Battaglia G
    Mol Pharmacol; 1994 Dec; 46(6):1111-9. PubMed ID: 7808431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vivo study of central serotoninergic receptors in man using positron tomography].
    Baron JC; Samson Y; Comar D; Crouzel C; Deniker P; Agid Y
    Rev Neurol (Paris); 1985; 141(8-9):537-45. PubMed ID: 2935920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.